Equities

MoonLake Immunotherapeutics

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MLTXN:MEX

MoonLake Immunotherapeutics

Actions
  • Price (MXN)305.30
  • Today's Change-10.92 / -3.45%
  • Shares traded120.00
  • 1 Year change--
  • Beta1.1863
Data delayed at least 20 minutes, as of Jan 15 2026 11:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, MoonLake Immunotherapeutics (MLTXN:MEX) closed at 305.30, 0.00% below its 52-week high of 305.30, set on Jan 15, 2026.
52-week range
305.30Jan 15 2026305.30Jan 15 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open305.30
High305.30
Low305.30
Bid--
Offer--
Previous close316.22
Average volume--
Shares outstanding71.37m
Free float63.16m
P/E (TTM)--
Market cap1.34bn USD
EPS (TTM)-3.33
USD
Data delayed at least 20 minutes, as of Jan 15 2026 11:30 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.